Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Reference44 articles.
1. Cheson BD, Bennett JM, Kantarjian H, et al.: Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood 2000, 96:3671–3674. The standard for clinical trial response criteria in myelodysplastic syndrome.
2. Silverman L: The myelodysplastic syndrome. In Cancer Medicine. Edited by Holland J, Frei E, Bast R, et al. Baltimore, Maryland: Williams and Wilkins; 1996:2593–2615.
3. Economopoulos T, Stathakis N, Foudoulakis A, et al.: Myelodysplastic syndromes: analysis of 131 cases according to the FAB classi.cation. Eur J Haematol 1987, 38:338–344.
4. Foucar K, Langdon RM, Armitage JO, et al.: Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases. Cancer 1985, 56:553–561.
5. Kerkhofs H, Hermans J, Haak HL, et al.: Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br J Haematol 1987, 65:73–81.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献